| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.01 | 1 |